（编辑 王雪儿） 证券日报网讯 1月30日，新华医疗在互动平台回答投资者提问时表示，公司近三年研发费用主要聚焦医 疗器械、制药装备两大核心主业，围绕高端化、智能化、绿色化方向开展核心技术攻关与产品创新，重 点投向高端放疗及影像设备、感染控制设备、微创手术器械及耗材、高端制药制剂装备等领域，同时布 局康复智能装备等前沿赛道，持续推进产品技术升级与国际化认证，筑牢核心技术壁垒。 ...

Group 1 - The stock price of Yuyue Medical is reported at 37.66 yuan, an increase of 1.06 yuan from the previous trading day, with an opening price of 37.23 yuan, a high of 38.12 yuan, and a low of 37.21 yuan, with a trading volume of 218,971 hands and a transaction amount of 826 million yuan [1] - Yuyue Medical operates in the medical device sector, focusing on the research, production, and sales of medical equipment, covering areas such as respiratory therapy, diabetes care, and infection control, aiming to deeply integrate digital technology with medical devices [1] - On August 23, the company hosted a research meeting with several institutions, including Boyuan Fund, to discuss its layout in the digital and wearable fields [1] Group 2 - In the second quarter, pension funds increased their holdings in Yuyue Medical, with a market value exceeding 100 million yuan, entering the company's top ten circulating shareholders [1] - On August 25, the net outflow of main funds was 40.90 million yuan, while the net inflow over the past five days was 73.03 million yuan [1]